TPG Capital Asia has wrapped up its $202.7 million acquisition of Quest Laboratories, Healthscope’s pathology business in Asia. Healthscope is one of Australia’s leading healthcare providers, listed on the Australian Exchange (ASX).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
